Abbott Laboratories (ABT) Income from Discontinued Operations (2014 - 2018)
Abbott Laboratories (ABT) reported Income from Discontinued Operations of 9000000.0 for Q1 2018, down 72.73% on a YoY basis from 33000000.0 in Q1 2017, and down 75.0% sequentially from 36000000.0 in Q4 2017.
Abbott Laboratories (ABT) Income from Discontinued Operations (2014 - 2018) Analysis & Trends
Abbott Laboratories (ABT) has 5 years of Income from Discontinued Operations data on file, last reported at 9000000.0 in Q1 2018.
- For the quarter ending Q1 2018, Income from Discontinued Operations fell 72.73% year-over-year to 9000000.0; the trailing twelve-month figure through Mar 2018 stood at 100000000.0 (down 9.09% YoY), and the FY2018 full-year result was 34000000.0, down 72.58% from the prior year.
- Income from Discontinued Operations eased to 9000000.0 in Q1 2018, from 36000000.0 in the prior quarter.
- In the past five years, Income from Discontinued Operations ranged from a high of 270000000.0 in Q4 2014 to a low of 32000000.0 in Q3 2015.
- A 5-year average of 63588235.29 and a median of 33000000.0 in 2016 frame the typical range for Income from Discontinued Operations.
- Across the five-year window, Income from Discontinued Operations tumbled 132.0% in 2015 and soared 1700.0% in 2016, its largest moves.
- Tracing ABT's Income from Discontinued Operations over 5 years: stood at 270000000.0 in 2014, then sank by 73.33% to 72000000.0 in 2015, then plunged by 54.17% to 33000000.0 in 2016, then advanced by 9.09% to 36000000.0 in 2017, then tumbled by 75.0% to 9000000.0 in 2018.
- Business Quant data shows ABT's Income from Discontinued Operations at 9000000.0 in Q1 2018, 36000000.0 in Q4 2017, and 42000000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | - |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | - |
| 10 | Steris | 21.53 Bn | 21.09 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 9.00 Mn |
| Dec 31, 2017 | 36.00 Mn |
| Sep 30, 2017 | 42.00 Mn |
| Jun 30, 2017 | 13.00 Mn |
| Mar 31, 2017 | 33.00 Mn |
| Dec 31, 2016 | 33.00 Mn |
| Sep 30, 2016 | 28.00 Mn |
| Jun 30, 2016 | 16.00 Mn |
| Mar 31, 2016 | 244.00 Mn |
| Dec 31, 2015 | 72.00 Mn |
| Sep 30, 2015 | -32.00 Mn |
| Jun 30, 2015 | -1.00 Mn |
| Mar 31, 2015 | 26.00 Mn |
| Dec 31, 2014 | 270.00 Mn |
| Sep 30, 2014 | 100.00 Mn |
| Jun 30, 2014 | 41.00 Mn |
| Mar 31, 2014 | 151.00 Mn |